Atea Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Atea Pharmaceuticals patents 23 in total

Status Patent
Application
Utility: BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 25 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 25 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19 External link
Filling date: 25 Sep 2025 Issue date: 9 Sep 2021
Application
Utility: NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 25 Sep 2025 Issue date: 25 Mar 2021
Grant
Utility: 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment External link
Filling date: 25 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus External link
Filling date: 25 Sep 2025 Issue date: 2 Feb 2021
Application
Utility: TREATMENT OF HCV INFECTED PATIENTS WITH CIRRHOSIS External link
Filling date: 25 Sep 2025 Issue date: 21 Jan 2021
Grant
Utility: Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus External link
Filling date: 25 Sep 2025 Issue date: 19 Jan 2021
Application
Utility: Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 25 Sep 2025 Issue date: 14 Jan 2021
Grant
Utility: Highly active compounds against COVID-19 External link
Filling date: 25 Sep 2025 Issue date: 29 Dec 2020
Grant
Utility: .beta.-d-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-c-substituted-2-modified-n.s- up.6-substituted purine nucleotides for HCV treatment External link
Filling date: 25 Sep 2025 Issue date: 29 Dec 2020
Grant
Utility: .beta.-D-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-C-substituted-2-modified-N.s- up.6-substituted purine nucleotides for HCV treatment External link
Filling date: 25 Sep 2025 Issue date: 22 Dec 2020
Grant
Utility: .beta.-D-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-C-substituted-2-modified-N6-- substituted purine nucleotides for HCV treatment External link
Filling date: 25 Sep 2025 Issue date: 22 Dec 2020
Grant
Utility: .beta.-D-2'-deoxy-2'-.alpha.-fluoro-2'-.beta.-C-substituted-2-modified-N.s- up.6-substituted purine nucleotides for HCV treatment External link
Filling date: 25 Sep 2025 Issue date: 27 Oct 2020
Application
Utility: BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 25 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: BETA-D-2'-DEOXY-2'-ALPHA-FLUORO-2'-BETA-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 25 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 25 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: Beta-D-2'-DEOXY-2'-Alpha-FLUORO-2'-Beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTI- TUTED PURINE NUCLEOTIDES FOR HCV TREATMENT External link
Filling date: 25 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: 2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT External link
Filling date: 25 Sep 2025 Issue date: 16 Jul 2020
Grant
Utility: Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'fluoro-n6-substitu- ted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection External link
Filling date: 25 Sep 2025 Issue date: 14 Jul 2020
Application
Utility: HIGHLY ACTIVE DRUG COMBINATION FOR TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 25 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS External link
Filling date: 25 Sep 2025 Issue date: 19 Mar 2020
Grant
Utility: Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus External link
Filling date: 25 Sep 2025 Issue date: 31 Dec 2019

Showing 1 to 23 of 23 patents.